These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 33111471

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Attenuation of phagocytosis of xenogeneic cells by manipulating CD47.
    Wang H, VerHalen J, Madariaga ML, Xiang S, Wang S, Lan P, Oldenborg PA, Sykes M, Yang YG.
    Blood; 2007 Jan 15; 109(2):836-42. PubMed ID: 17008545
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CD47 Deficiency in Mice Exacerbates Chronic Fatty Diet-Induced Steatohepatitis Through Its Role in Regulating Hepatic Inflammation and Lipid Metabolism.
    Tao HC, Chen KX, Wang X, Chen B, Zhao WO, Zheng Y, Yang YG.
    Front Immunol; 2020 Jan 15; 11():148. PubMed ID: 32158445
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα-CD47 innate immune checkpoint.
    Voets E, Paradé M, Lutje Hulsik D, Spijkers S, Janssen W, Rens J, Reinieren-Beeren I, van den Tillaart G, van Duijnhoven S, Driessen L, Habraken M, van Zandvoort P, Kreijtz J, Vink P, van Elsas A, van Eenennaam H.
    J Immunother Cancer; 2019 Dec 04; 7(1):340. PubMed ID: 31801627
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. RRx-001, a downregulator of the CD47- SIRPα checkpoint pathway, does not cause anemia or thrombocytopenia.
    Oronsky B, Cabrales P, Caroen S, Guo X, Scribner C, Oronsky A, Reid TR.
    Expert Opin Drug Metab Toxicol; 2021 Apr 04; 17(4):355-357. PubMed ID: 33432831
    [Abstract] [Full Text] [Related]

  • 13. Human CD47 expression permits survival of porcine cells in immunodeficient mice that express SIRPα capable of binding to human CD47.
    Wang C, Wang H, Ide K, Wang Y, Van Rooijen N, Ohdan H, Yang YG.
    Cell Transplant; 2011 Apr 04; 20(11-12):1915-20. PubMed ID: 21535911
    [Abstract] [Full Text] [Related]

  • 14. Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell Binding.
    Puro RJ, Bouchlaka MN, Hiebsch RR, Capoccia BJ, Donio MJ, Manning PT, Frazier WA, Karr RW, Pereira DS.
    Mol Cancer Ther; 2020 Mar 04; 19(3):835-846. PubMed ID: 31879362
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model.
    Lysenko V, Schürch PM, Tuzlak S, van Wijk NW, Kovtonyuk LV, Becher B, Manz MG, Kreutmair S, Theocharides APA.
    Leukemia; 2023 Jun 04; 37(6):1277-1286. PubMed ID: 37095207
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. SIRPα-Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells.
    Piccione EC, Juarez S, Tseng S, Liu J, Stafford M, Narayanan C, Wang L, Weiskopf K, Majeti R.
    Clin Cancer Res; 2016 Oct 15; 22(20):5109-5119. PubMed ID: 27126995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.